Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'r pfi 2 hydrochloride'

Search results for: 'r pfi 2 hydrochloride'

Items 51-60 of 60

Page
per page
  1. Reversine
    A3760 Reversine
    Target: Aurora Kinases
    Summary: A3 adenosine receptor antagonist,ARK-1/-2/-3 inhibitor
      insoluble in H2O; ≥19.65 mg/mL
  2. CCT241533
    A3291 CCT241533
    Target: Chk
    Summary: Potent Chk2 inhibitor
      Soluble in DMSO
  3. CYT997 (Lexibulin)
    B1635 CYT997 (Lexibulin)
    Summary: Potent microtubule polymerization inhibitor
      Soluble in DMSO
  4. ABT-751 (E7010)
    A1493 ABT-751 (E7010)
     1 Citation
    Target: Microtubules/Tubulins
    Summary: Inhibitor of microtubule polymerization,antimitotic
      insoluble in H2O; ≥18.55 mg/mL
  5. NMS-1286937
    B4094 NMS-1286937
    Target: PLK
    Summary: PLK1 inhibitor, orally bioavailable
      insoluble in H2O; insoluble in EtOH; ≥13.33 mg/mL
  6. CVT-313
    A3336 CVT-313
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Cdk2 inhibitor
      ≥20 mg/mL
  7. GSK461364
    A8441 GSK461364
     3 Citation
    Target: PLK
    Summary: Plk1 inhibitor
  8. SNS-032 (BMS-387032)
    A1980 SNS-032 (BMS-387032)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor
      insoluble in H2O; ≥19.05 mg/mL
  9. SB1317
    A3794 SB1317
    Summary: CDK,JAK and FLT inhibitor
      insoluble in H2O; ≥44.87 mg/mL
  10. JNJ-7706621
    A4115 JNJ-7706621
     1 Citation
    Target: Cyclin-Dependent Kinases|Aurora Kinases
    Summary: Potent CDK/Aurora kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.7 mg/mL

Items 51-60 of 60

Page
per page